POSEIDA THERAPEUTICS INC (PSTX) Institutional Ownership
None of the superinvestors we track currently report POSEIDA THERAPEUTICS INC (PSTX) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in POSEIDA THERAPEUTICS INC (PSTX), this page will show institutional position trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2024 | 1 | $2,603,520 | 271,200 |
| Q3 2024 | 1 | $2,567,145 | 897,603 |
| Q2 2024 | 1 | $2,496,308 | 854,900 |
| Q1 2024 | 1 | $1,778 | 557,400 |
| Q4 2023 | 1 | $1,781 | 530,100 |
| Q3 2023 | 1 | $1,864 | 783,071 |
| Q2 2023 | 1 | $950 | 540,024 |
| Q1 2023 | 1 | $1,858 | 603,200 |
| Q4 2022 | 1 | $1,040 | 196,300 |
| Q3 2022 | 1 | $1,212 | 343,300 |
| Q2 2022 | 1 | $981 | 380,100 |
| Q1 2022 | 1 | $838 | 187,000 |
Related PSTX Institutional Insights:
- PSTX Institutional Ownership & Insiders Activity
- PSTX Institutional Ownership & 13F Activity
- PSTX Top Institutional Shareholders
- PSTX Institutional Buying Activity
- PSTX Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- PSTX Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings